University of Colorado Hospital and University of Colorado School of Pharmacy
This PGY2 residency is designed to develop competencies necessary for specialized practice in infectious diseases pharmacotherapy. The program is individualized to meet needs and interests of the resident. Additional opportunities for participation in clinical research are available.
The primary training site for the residency is the University of Colorado Hospital (UCH). The School of Pharmacy, part of the Anschutz Medical Campus of the University of Colorado, is also closely affiliated with the program. PGY2 residents will be involved in teaching programs of the school, including didactic and clerkship teaching of PharmD students and pharmacy practice residents, as well as medical residents and infectious diseases fellows.
While the program focuses on enhancing clinical skills, a research project is required for successful completion of the residency. An administrative project (e.g., MUE) will also be required. Additionally, residents will gain experience in medical writing and publishing.
Upon completion of this residency, graduates will be prepared to practice as an infectious diseases pharmacotherapy specialist in either a community or academic environment.
A similar program at the University of Colorado was previously ASHP accredited from 2001-2006. The current program is in Pre-Candidate status with ASHP and will be applying for accreditation at the conclusion of the 2012-2013 residency year.
The inpatient and outpatient services of the University of Colorado Hospital provide the primary teaching sites for this program. Other rotation sites may include other hospitals in the Denver area offering unique learning experiences not available at the University of Colorado Hospital.
Rotations are usually scheduled in four-week increments. Required clinical rotations include two months with the general infectious diseases inpatient consult service, two months of transplant ID consult service, two months in HIV/AIDS & hepatitis, and longitudinal experiences in antimicrobial stewardship and the outpatient infectious diseases clinic. A rotation in one of the critical care units of the hospital is also encouraged. Residents will also have opportunities to receive training in basic microbiological techniques and laboratory processes.
Possible elective rotations include: pediatric infectious diseases, bone marrow transplant/oncology, pulmonary/cystic fibrosis service, research, and others.
Doctorate of Pharmacy Degree (ACPE accredited) and PGY1 Pharmacy Residency
Douglas Fish, PharmD
Clinical Specialist in ID/Critical Care, Residency Program Director
Tiffany Goolsby, PharmD
Clinical Specialist in Infectious Diseases
Jasjit Gill, PharmD
Clinical Specialist in Infectious Diseases and HIV/AIDS
Jacob Langness, PharmD
Clinical Specialist in HIV/AIDS and Hepatology
Gerry Barber, PharmD
Coordinator, Clinical Pharmacy Services
PGY2 resident salary is $41,000 per year (2012-13). Benefits include: healthcare coverage, 23 days annual leave (including meetings and sick days), and a travel stipend. Residents receive an appointment as Clinical Instructor in the School of Pharmacy. Limited staffing (160 hours) is expected of all University of Colorado residents.
Interested applicants meeting the above criteria should electronically submit a letter of intent, curriculum vitae, academic transcripts, and three letters of recommendation through ASHP’s Pharmacy Online Residency Centralized Application Service (PhORCAS). PhORCAS is the preferred method of applying for this program. If you will not be participating in PhORCAS, please contact the Residency Program Director at firstname.lastname@example.org for additional application instructions.
The deadline for receipt of all application materials, whether using PhORCAS or not, is no later than January 1, 2013.
PGY2 Infectious Diseases Residency Information 2013-2014 (revised 9-17-2012)
Current and Previous Residents and Fellows